Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Gustoeson Aug 22, 2017 9:12am

108 Views

Post# 26606757

RE:RE:RE:News

Here is a 2014 article re ru dyads, the "PS" photosensizers referenced are actually tld 1411 and 1433

They tested against leukemia cancer cell line (HL-60)

In vitro PDT dose–response curves for complex 3b in HL-60 cells. PDT-treated samples were irradiated with 100 J cm−2 of (a) visible light or (b) red light with drug-to-light intervals of 16 h

Figure 3b is TLD 1433

We're scratching the surface.

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments